ORIC Pharamceuticals (ORIC) PT Raised to $17 at Oppenheimer, 'Executing On Multiple Fronts'
Tweet Send to a Friend
Oppenheimer analyst Matthew Biegler raised the price target on ORIC Pharamceuticals (NASDAQ: ORIC) to $17.00 (from $14.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
